In-home walking speeds and variability trajectories associated with mild cognitive impairment

Objective: To determine whether unobtrusive long-term in-home assessment of walking speed and its variability can distinguish those with mild cognitive impairment (MCI) from those with intact cognition. Methods: Walking speed was assessed using passive infrared sensors fixed in series on the ceiling of the homes of elderly individuals participating in the Intelligent Systems for Assessing Aging Change (ISAAC) cohort study. Latent trajectory models were used to analyze weekly mean speed and walking speed variability (coefficient of variation [COV]). Results: ISAAC participants living alone included 54 participants with intact cognition, 31 participants with nonamnestic MCI (naMCI), and 8 participants with amnestic MCI at baseline, with a mean follow-up of 2.6 ± 1.0 years. Trajectory models identified 3 distinct trajectories (fast, moderate, and slow) of mean weekly walking speed. Participants with naMCI were more likely to be in the slow speed group than in the fast (p = 0.01) or moderate (p = 0.04) speed groups. For COV, 4 distinct trajectories were identified: group 1, the highest baseline and increasing COV followed by a sharply declining COV; groups 2 and 3, relatively stable COV; and group 4, the lowest baseline and decreasing COV. Participants with naMCI were more likely to be members of either highest or lowest baseline COV groups (groups 1 or 4), possibly representing the trajectory of walking speed variability for early- and late-stage MCI, respectively. Conclusion: Walking speed and its daily variability may be an early marker of the development of MCI. These and other real-time measures of function may offer novel ways of detecting transition phases leading to dementia.

[1]  Jeffrey Kaye,et al.  The trajectory of gait speed preceding mild cognitive impairment. , 2010, Archives of neurology.

[2]  Charles Hall,et al.  Validity of Divided Attention Tasks In Predicting Falls in Older Individuals: A Preliminary Study , 2002, Journal of the American Geriatrics Society.

[3]  Xiaonan Xue,et al.  Gait Dysfunction in Mild Cognitive Impairment Syndromes , 2008, Journal of the American Geriatrics Society.

[4]  A. Levey,et al.  Diffuse Plaques in the Striatum in Alzheimer Disease (AD): Relationship to the Striatal Mosaic and Selected Neuropeptide Markers , 1997, Journal of neuropathology and experimental neurology.

[5]  Sascha Köpke,et al.  Der Tinetti-Test – Babylon im geriatrischen Assessment , 2006 .

[6]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .

[7]  J. Kaye,et al.  Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline , 2008, Neurology.

[8]  G. Baron,et al.  Mobility decline of unknown origin in mild cognitive impairment: An MRI-based clinical study of the pathogenesis , 2008, Brain Research.

[9]  J. Barth,et al.  The Halstead-Reitan Neuropsychological Test Battery. , 2000 .

[10]  T. Hayes,et al.  One walk a year to 1000 within a year: continuous in-home unobtrusive gait assessment of older adults. , 2012, Gait & posture.

[11]  Jeffrey M. Hausdorff,et al.  A Common Cognitive Profile in Elderly Fallers and in Patients with Parkinson's Disease: The Prominence of Impaired Executive Function and Attention , 2006, Experimental aging research.

[12]  M. Tinetti Performance‐Oriented Assessment of Mobility Problems in Elderly Patients , 1986, Journal of the American Geriatrics Society.

[13]  J. Kaye,et al.  Motor slowing precedes cognitive impairment in the oldest old , 1998, Neurology.

[14]  Xiaonan Xue,et al.  Cognitive processes related to gait velocity: results from the Einstein Aging Study. , 2006, Neuropsychology.

[15]  Changyu Shen,et al.  Application of the Pattern-Mixture Latent Trajectory Model in an Epidemiological Study with Non-Ignorable Missingness. , 2008, Journal of data science : JDS.

[16]  Misha Pavel,et al.  Unobtrusive and Ubiquitous In-Home Monitoring: A Methodology for Continuous Assessment of Gait Velocity in Elders , 2010, IEEE Transactions on Biomedical Engineering.

[17]  J. Kaye,et al.  Talking while walking , 1997, Neurology.

[18]  K. Jellinger,et al.  Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs , 2006, Acta Neuropathologica.

[19]  K. Roeder,et al.  A SAS Procedure Based on Mixture Models for Estimating Developmental Trajectories , 2001 .

[20]  Nathaniel Mercaldo,et al.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.

[21]  S. MacDonald,et al.  Intra-individual variability in behavior: links to brain structure, neurotransmission and neuronal activity , 2006, Trends in Neurosciences.

[22]  E G Tangalos,et al.  Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.

[23]  M. Pavel,et al.  Intelligent Systems For Assessing Aging Changes: home-based, unobtrusive, and continuous assessment of aging. , 2011, The journals of gerontology. Series B, Psychological sciences and social sciences.

[24]  Andre Gustavo Adami,et al.  Unobtrusive assessment of activity patterns associated with mild cognitive impairment , 2008, Alzheimer's & Dementia.

[25]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[26]  David A Bennett,et al.  Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. , 2006, Archives of neurology.

[27]  C. Reynolds,et al.  Wechsler memory scale-revised , 1988 .

[28]  D. Wedding Halstead‐Reitan Neuropsychological Test Battery , 2010 .

[29]  R. Kraftsik,et al.  Primary motor cortex involvement in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[30]  J. Morris,et al.  Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.

[31]  C. Ascaso,et al.  Effects of Thyroid Hormone on mRNAs of Phosphoglycerate Mutase Subunits in Rat Muscle during Development , 2002, Hormone Research in Paediatrics.

[32]  M P Lawton,et al.  Validation of the Cumulative Illness Rating Scale in a Geriatric Residential Population , 1995, Journal of the American Geriatrics Society.

[33]  T. L. Brink,et al.  Clinical Gerontology: A Guide to Assessment and Intervention , 1986 .

[34]  H. Dodge,et al.  Cognitive domains and trajectories of functional independence in nondemented elderly persons. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[35]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[36]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[37]  J. Kordower,et al.  Substantia nigra tangles are related to gait impairment in older persons , 2006, Annals of neurology.

[38]  T. Kurosaki,et al.  Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.

[39]  Gabriele Meyer,et al.  The Tinetti test: Babylon in geriatric assessment. , 2006, Zeitschrift fur Gerontologie und Geriatrie.

[40]  Herman Buschke,et al.  Abnormality of gait as a predictor of non-Alzheimer's dementia. , 2002, The New England journal of medicine.

[41]  D. Briley,et al.  Older people with impaired mobility have specific loci of periventricular abnormality on MRI. , 2002, Neurology.

[42]  E. Kaplan,et al.  The Boston naming test , 2001 .

[43]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.